Feasibility Study: Continuous ECG and Blood Pressure Monitoring With the M2VS Sensor System
NCT: NCT07694570 · NOT_YET_RECRUITING
Brief Summary
In this study, the investigators want to find out whether a new wearable sensor system, called the M2VS system, can reliably measure heart activity, blood pressure, and other vital signs over 24 hours during normal daily life. The investigators also want to compare the M2VS system with the standard devices currently used for long-term heart and blood pressure monitoring, such as a Holter ECG and an ambulatory blood pressure monitor (ABPM). This will provide an estimation of the accuracy of the M2VS system's ECG and blood pressure measurements compared to the standard devices. The aim of the study is to assess how reliable the M2VS system is in terms of data completeness and how comfortable it is to wear compared with the usual monitoring devices. In the future, the results of this study may help make the monitoring of heart and blood vessel diseases more comfortable and easier for patients.
Frequently Asked Questions
What is Feasibility Study: Continuous ECG and Blood Pressure Monitoring With the M2VS Sensor System?
Feasibility Study: Continuous ECG and Blood Pressure Monitoring With the M2VS Sensor System is a clinical trial registered under NCT07694570. Current status: NOT_YET_RECRUITING.
What is the status of NCT07694570?
The current status of NCT07694570 (Feasibility Study: Continuous ECG and Blood Pressure Monitoring With the M2VS Sensor System) is: NOT_YET_RECRUITING.
When did Feasibility Study: Continuous ECG and Blood Pressure Monitoring With the M2VS Sensor System start?
Feasibility Study: Continuous ECG and Blood Pressure Monitoring With the M2VS Sensor System started on 2026-07-01.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.